These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25820158)

  • 1. Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease.
    Bochenek G; Szafraniec K; Kuschill-Dziurda J; Nizankowska-Mogilnicka E
    Respir Med; 2015 May; 109(5):588-95. PubMed ID: 25820158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
    Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
    J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
    Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
    Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
    Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
    Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Tan JHY; Hsu AAL
    Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of parecoxib in asthmatic patients with aspirin-exacerbated respiratory disease.
    Valero A; Sánchez-López J; Bartra J; Serrano C; Muñoz-Cano R; Roca J; Picado C
    Int Arch Allergy Immunol; 2011; 156(2):221-3. PubMed ID: 21597303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of immunoglobulin E responses to staphylococcal superantigens in patients with aspirin-exacerbated respiratory disease.
    Yoo HS; Shin YS; Liu JN; Kim MA; Park HS
    Int Arch Allergy Immunol; 2013; 162(4):340-5. PubMed ID: 24193355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of tapasin polymorphisms with aspirin-exacerbated respiratory disease in asthmatics.
    Cho SH; Park JS; Park BL; Bae DJ; Uh ST; Kim MK; Choi IS; Shin HD; Park CS
    Pharmacogenet Genomics; 2013 Jul; 23(7):341-8. PubMed ID: 23736108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated total serum IgE in nonatopic patients with aspirin-exacerbated respiratory disease.
    Johns CB; Laidlaw TM
    Am J Rhinol Allergy; 2014; 28(4):287-9. PubMed ID: 25197914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The frequency of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) in the population of adult asthmatics in Poland based on an epidemiological questionnaire].
    Kasper Ł; Sładek K; Bochenek G; Duplaga M; Szczeklik A
    Pneumonol Alergol Pol; 2009; 77(5):431-9. PubMed ID: 19890822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perimenstrual Asthma in Aspirin-Exacerbated Respiratory Disease.
    Eid RC; Palumbo ML; Cahill KN
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):573-578.e4. PubMed ID: 31580922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a multicenter randomized control crossover trial.
    Sommer DD; Rotenberg BW; Sowerby LJ; Lee JM; Janjua A; Witterick IJ; Monteiro E; Gupta MK; Au M; Nayan S
    Int Forum Allergy Rhinol; 2016 Apr; 6(4):385-91. PubMed ID: 26751262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease.
    Mitsui C; Kajiwara K; Hayashi H; Ito J; Mita H; Ono E; Higashi N; Fukutomi Y; Sekiya K; Tsuburai T; Akiyama K; Yamamoto K; Taniguchi M
    J Allergy Clin Immunol; 2016 Feb; 137(2):400-11. PubMed ID: 26194538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
    Rajan JP; Wineinger NE; Stevenson DD; White AA
    J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease.
    Jean T; Eng V; Sheikh J; Kaplan MS; Goldberg B; Jau Yang S; Samant S
    Allergy Asthma Proc; 2019 Sep; 40(5):316-320. PubMed ID: 31514790
    [No Abstract]   [Full Text] [Related]  

  • 18. Comorbid diseases in aspirin-exacerbated respiratory disease, and asthma.
    Erdogan T; Karakaya G; Kalyoncu AF
    Allergol Immunopathol (Madr); 2015; 43(5):442-8. PubMed ID: 25547458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma.
    Bochenek G; Stachura T; Szafraniec K; Plutecka H; Sanak M; Nizankowska-Mogilnicka E; Sladek K
    J Allergy Clin Immunol Pract; 2018; 6(2):528-535. PubMed ID: 28888846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-13 and IL-17A gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease.
    Kohyama K; Abe S; Kodaira K; Yukawa T; Hozawa S; Sagara H; Kurosawa M
    Ann Allergy Asthma Immunol; 2011 Dec; 107(6):510-6. PubMed ID: 22123380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.